Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Spectral TMS (s-TMS) [NA]

View source ↗

Summary

Spectral TMS is being studied for Major Depressive Disorder in a UCLA-sponsored trial that is enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spectral TMS

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depressive Disorder | NA | Status: ENROLLING_BY_INVITATION